H021 Enteric-coated Tablets Low-dose Group: Clinical Trials

1 trial of H021 Enteric-coated Tablets Low-dose Group, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1

Follow H021 Enteric-coated Tablets Low-dose Group: new trials by email Literature Review of H021 Enteric-coated Tablets Low-dose Group trials Research Report on H021 Enteric-coated Tablets Low-dose Group

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease
H021 Enteric-coated Tablets Low-dose Group, H021 Enteric-coated Tablets High-dose Group, Placebo Group - Crohn's Disease
Phase 2Not yet recruitingJiangsu Carephar Pharmaceutical Co., Ltd.1562026-07-122026-06-30

Conditions studied

Crohn Disease (1)

Sponsors

Jiangsu Carephar Pharmaceutical Co., Ltd. (1)

Countries

China (1)  ·  United States (1)